The single biggest category of spending in innovative R&D is clinical development, and the costs for clinical studies were increased dramatically over the years, but with no proportional rise in the rate of new drug approvals. It is therefore crucial to use various managerial, strategic and scientific methodologies in order to improve the efficiency and probability of success in future...
Continue reading
The single biggest category of spending in innovative R&D is clinical development, and the costs for clinical studies were increased dramatically over the years, but with no proportional rise in the rate of new drug approvals.
It is therefore crucial to use various managerial, strategic and scientific methodologies in order to improve the efficiency and probability of success in future clinical studies.
The seminar sheds light on the challenges and opportunities that the innovative drug developers in the pharmaceutical industry are facing, and discuss some of the most useful tools that might contribute to better planning, designing and executing of clinical trials. Implementation of these approaches will lead to speed and success rates enhancement while reducing costs.
Close